Guest View
User: Pass: | become a member
Author Archive for Insider Scoop

Bank of America Downgrades Ocwen Financial To Neutral

Courtesy of Benzinga.

Related OCN
Ocwen Financial Shares Get Crushed, Bank Of America Downgrades
Markets In Rally Mode: S&P 500 And Nasdaq Surge As Dow Lags

Analysts at Bank of America downgraded Ocwen Financial (NYSE: OCN) from Buy to Neutral.

The price target for Ocwen Financial has been lowered from $35 to $23.

Ocwen Financial shares have dropped 24.28% over the past 52 weeks, while the S&P 500 index has gained 10.64% in the same period.

Ocwen Financial’s shares dropped 6.70% to $20.04 in pre-market trading.

Latest Ratings for OCN

Date Firm Action From To
Oct 2014 Bank of America Downgrades Buy Neutral
Sep 2014 Barclays Reinstates Equal-weight
Aug 2014 Oppenheimer Downgrades Outperform Market Perform

View More Analyst Ratings for OCN
View the Latest Analyst Ratings

Posted-In: Bank of AmericaDowngrades Analyst Ratings

Oppenheimer Initiates 3D Systems At Outperform

Courtesy of Benzinga.

Related DDD
3D Systems Issues Profit Warning, Shares Tumble
Five 3D Printed Body Parts Debuts First 3D Printer for 3D Systems (Fox Business)

Analysts at Oppenheimer initiated coverage on shares of 3D Systems (NYSE: DDD) with a Outperform rating.

The target price for 3D Systems is set to $57.

3D Systems shares have dropped 24.28% over the past 52 weeks, while the S&P 500 index has gained 10.64% in the same period.

3D Systems’ shares tumbled 10.74% to $38.72 in pre-market trading.

Latest Ratings for DDD

Date Firm Action From To
Oct 2014 Oppenheimer Initiates Coverage on Outperform
Sep 2014 Pacific Crest Downgrades Outperform Sector Perform
Sep 2014 Morgan Stanley Initiates Coverage on Equal-weight

View More Analyst Ratings for DDD
View the Latest Analyst Ratings

Posted-In: OppenheimerInitiation Analyst Ratings

UPDATE: Brean Capital Initiates Coverage On GrubHub

Courtesy of Benzinga.

Related GRUB
UPDATE: JMP Securities Initiates Coverage On GrubHub Inc
Benzinga's Top Initiations
Making Money With Charles Payne: 09/25/14 (Fox Business)

Brean Capital initiated coverage on GrubHub Inc (NYSE: GRUB) with a Hold rating.

Analyst Tom Forte noted that "catalysts for the stock include an acceleration in active diner growth or take rate in 3Q14. In our view, its $36.86 share price adequately reflects our favorable opinion of GrubHub and its business model. We would be comfortable recommending their purchase if there was a pullback."

Forte commented that "the company is leading the way as consumers increasingly use their connected devices, including their smartphones, to order online from restaurants instead of calling in their orders and relying on physical menus. Today, only 5 percent of take- out orders are placed online."

"Investor sentiment is already favorable, which is reflected in the high multiples (shares currently trade at an 87.8x forward P/E ratio and 31.9x forward EV/EBITDA). However; we are not forecasting an acceleration, with pro forma active diner growth of 45.0 percent vs. 50.7 percent last quarter and a pro forma take rate of 12.0 percent vs. 14.2 percent last quarter," according to the report.

GrubHub Inc recently traded at $36.81, down 0.38 percent.

Latest Ratings for GRUB

Date Firm Action From To
Oct 2014 Brean Capital Initiates Coverage on Hold
Oct 2014 CRT Capital Initiates Coverage on Buy
Oct 2014 JMP Securities Initiates Coverage on Market Outperform

View More Analyst Ratings for GRUB
View the Latest Analyst Ratings

Posted-In: Brean Capital Tom ForteAnalyst Color Initiation Analyst Ratings

Innocoll AG Proposes Changes To Supervisory Board And Stock Option Plan

Courtesy of Benzinga.

Related INNL
Benzinga's Top Initiations
Stifel Nicolas Initiates Innocoll At Buy

Innocoll AG (Nasdaq: INNL), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical products and medical devices using its proprietary collagen-based technologies, today posted to shareholders a proposal to elect Joseph Wiley, M.D., a principal at Sofinnova Ventures, to its Supervisory Board. The Company also announced that Anthony H. Wild, Ph.D., has resigned from Innocoll’s Supervisory Board. If Dr. Wiley’s election is approved, Innocoll will have completed the new composition of its new Supervisory Board. In addition, the Supervisory Board is seeking shareholder support for a stock option plan that will enable it to strengthen and retain the team that will take Innocoll into the commercial stage of its development.

If elected, Dr. Wiley will join other recently appointed Supervisory Board members; Jonathan Symonds, Chairman of the Supervisory Board and former chief financial officer of both Novartis and AstraZeneca, David Brennan, former chief executive officer of AstraZeneca, and Shumeet Banerji, Ph.D., former chief executive officer of Booz & Company. Existing members of the Supervisory Board who will continue to serve in that capacity are A. James Culverwell and Rolf Schmidt.

“We have assembled a highly experienced Supervisory Board comprised of individuals whose corporate and industry expertise is commensurate with the ambitions the Company has for its collagen based products,” said Jonathan Symonds, Chairman of the Supervisory Board. “I look forward to working with these experienced executives and the management team as Innocoll moves to transition into a fully integrated specialty pharmaceutical company.”

Dr. Wiley has over 20 years of experience in the pharmaceutical, medical and venture capital industries. He was previously a medical director at Astellas Pharma. Prior to joining Astellas, he held investment roles at Spirit Capital, Inventages Venture Capital and Aberdeen Asset Managers (UK). Dr. Wiley trained in general medicine at Trinity College Dublin, specializing in neurology. He is also a Member of the Royal College of Physicians in Ireland.

Innocoll also will be seeking shareholder approval to reserve up to 10% of its shares outstanding as contingent capital underlying its proposed stock option plan. This plan will be…
continue reading

Phillips 66 Partners Announces Acquisition of Strategic Logistics Assets

Courtesy of Benzinga.

Phillips 66 Partners LP (NYSE: PSXP) (the “Partnership”) has reached an agreement to acquire from Phillips 66 (NYSE: PSX) two newly constructed crude oil rail-unloading facilities, located in Linden, New Jersey, and Ferndale, Washington, for $330 million as well as certain assets associated with the Cross-Channel Connector Pipeline for an additional $10 million. The acquisition, which is anticipated to close in early December 2014, is expected to be immediately accretive to unitholders.

“The acquisition of these high-quality logistics assets will enhance both the composition and geographic diversity of the Partnership’s portfolio,” said Greg Garland, Phillips 66 Partners chairman and CEO. “These strategically positioned assets will allow us to deliver on our plans for achieving top-quartile distribution growth.”

The assets to be acquired include:

The Bayway Rail-unloading Facility located within the Phillips 66 Bayway Refinery. This facility started commercial operations in August 2014, and is capable of unloading 120 railcars simultaneously, with a crude-unloading capacity of 75,000 barrels per day.
The Ferndale Rail-unloading Facility located adjacent to the Phillips 66 Ferndale Refinery. This facility is scheduled to begin commercial operations in November 2014 and will be capable of unloading 54 railcars simultaneously with a crude-unloading capacity of 30,000 barrels per day.
The Cross-Channel Connector Pipeline assets consisting of an active 2.5-mile, 20-inch diameter refined products pipeline, as well as an idled, 2.6-mile, 20-inch diameter refined products pipeline that runs under the Houston Ship Channel. The active segment currently transports refined products between the Partnership’s Pasadena Terminal and Kinder Morgan’s Pasadena Terminal.
Upon closing of the acquisition, the Partnership plans to utilize the Cross-Channel Connector Pipeline assets to develop and undertake a new organic project to provide shippers access from the Partnership’s Pasadena Terminal to third-party systems located north of the Houston Ship Channel. The project is expected to have additional capital costs of $12.4 million and is underwritten by long-term transportation service agreements with multiple shippers. The pipeline system will have an initial capacity of up to 180,000 barrels per day and is anticipated to commence commercial operations in the second quarter of 2015.

In connection with the closing, Phillips 66 and the Partnership will enter into 10-year terminal services agreements for 100 percent…
continue reading

Westell Technologies Announces New Sr. VP Of Worldwide Sales

Courtesy of Benzinga.

Related WSTL
10 Top Stocks Under $10 Right Now
Morning Market Losers

Westell Technologies, Inc. (NASDAQ: WSTL), a leading provider of in-building wireless, intelligent site management, cell site optimization, and outside plant solutions, announces the appointment of Mark Skurla as the Company’s new Senior Vice President of Worldwide Sales.

Mr. Skurla returned to Westell effective October 21, 2014. Since April of 2011, with the sale of the Westell Customer Networking Solutions business unit to NETGEAR, Inc., he has been serving as the Vice President of Sales for the Americas, Service Provider Business Unit at NETGEAR. Skurla was leading the Americas sales efforts to the mobile, cable, and telco service provider markets. He previously held executive positions with ADC Telecommunications, Copper Mountain Networks, and Visual Networks.

“With his industry knowledge and experience, we are pleased that Mark has re-joined the executive team of Westell,” stated Rick Gilbert, Chairman and Chief Executive Officer of Westell. “His strong leadership and understanding of customers as well as the telecommunications market will help us strategically grow our business in wireless markets globally.”

Posted-In: News Management Press Releases

Benzinga's Top #PreMarket Gainers

Courtesy of Benzinga.

Related SGYP
Anacor Pharmaceuticals, Inc. (ANAC) in Focus: Stock Surges 6.76% – Tale of the Tape
US Stock Futures Down; Alcoa Earnings In Focus

Related ILMN
Illumina Spikes 10% On Q3 Earnings Beat
Earnings Scheduled For October 20, 2014
Making Money With Charles Payne: 09/26/14 (Fox Business)

Synergy Pharmaceuticals (NASDAQ: SGYP) shares jumped 13.14% to $3.10 in pre-market trading after the company presented positive Phase 2b study results for Plecanatide in patients with irritable bowel syndrome with constipation.

Illumina (NASDAQ: ILMN) shares jumped 8.60% to $178.62 in pre-market trading after the company reported upbeat quarterly earnings and raised its earnings guidance for the full year.

Harley-Davidson (NYSE: HOG) shares rose 7.74% to $62.90 in pre-market trading after the company posted better-than-expected earnings for the third quarter.

Inovio Pharmaceuticals (NASDAQ: INO) gained 6.48% to $12.98 after the company reported that the DARPA has awarded $12.2 million for a collaborative study that will be conducted by scientists from the Perelman School of Medicine at the University of Pennsylvania; Inovio Pharmaceuticals; and MedImmune.

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers

Benzinga's Top Upgrades

Courtesy of Benzinga.

Related CHTR
Macquarie Upgrades Charter Communications to Outperform
Macquarie Upgrades Charter Communications To Outperform
AT&T: DirecTV Deal Will Create Comcast Rival (Fox Business)

Related PXD
Guggenheim Securities Upgrades Pioneer Natural Resources To Buy
Events for the Week of Oct. 13-17, 2014
Oil Refiners Tumble, Producers Rally on Export Ruling (Fox Business)

Macquarie upgraded Charter Communications (NASDAQ: CHTR) from Neutral to Outperform. The price target for Charter Communications is set to $155. Charter Communications’ shares closed at $148.18 yesterday.

Guggenheim Securities upgraded Pioneer Natural Resources Company (NYSE: PXD) from Neutral to Buy. The price target for Pioneer Natural Resources has been lowered from $216.00 to $206.00. Pioneer Natural Resources’ shares closed at $179.71 yesterday.

Analysts at Global Hunter upgraded Devon Energy (NYSE: DVN) from Neutral to Accumulate. The price target for Devon Energy has been lowered from $80.00 to $68.00. Devon Energy’s shares closed at $57.98 yesterday.

Analysts at Janney Capital upgraded Illumina (NASDAQ: ILMN) from Neutral to Buy. The price target for Illumina has been raised from $165.00 to $192.00. Illumina’s shares closed at $164.47 yesterday.

Latest Ratings for CHTR

Date Firm Action From To
Oct 2014 Macquarie Upgrades Neutral Outperform
Sep 2014 Canaccord Genuity Initiates Coverage on Buy
Jul 2014 Albert Fried & Co. Suspends Market Perform

View More Analyst Ratings for CHTR
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

Credit Suisse Cuts IBM Price Target

Courtesy of Benzinga.

Related IBM
Worst Performing Industries For October 21, 2014
Stocks Hitting 52-Week Lows
Weaker IBM Earnings Weigh on Stocks (Fox Business)

Credit Suisse slashed its price target on International Business Machines Corp. (NYSE: IBM) from $160 to $125 in a report issued Tuesday. An Underperform rating was maintained.

The change came after IBM reported disappointing 3Q 2014 earnings.

Analyst Kulbinder Garcha believed that "resetting expectations is a positive, and secular issues are now being increasingly reflected in shares. Nevertheless, despite a forthcoming mainframe cycle, we remain concerned that the fundamental headwinds facing IBM are challenging and accelerating."

Garcha noted several issues with the company, "First, services backlog was down 7 percent and 3Q margins came in at 17.7 percent the lowest level in 2 years, breaking consistent improvement. Second, software revenues were down 2 percent as reported."

The report concluded that "IBM continues to face multiple issues to revenue growth including high mainframe exposure, negative cloud impact and weak IT spending."

The report assumed "2014/2015 revenues of $94.4bn/$88bn, down 5 percent/7 percent" and applied a 10x FCF of $12.64 per share for the $125 price target.

International Business Machines Corp. recently traded at $163.07, down 3.5 percent.

Latest Ratings for IBM

Date Firm Action From To
Oct 2014 Barclays Maintains Equal-weight
Oct 2014 Credit Suisse Maintains Underperform
Oct 2014 Jefferies Maintains Underperform

View More Analyst Ratings for IBM
View the Latest Analyst Ratings

Posted-In: Credit Suisse Kulbinder GarchaAnalyst Color Price Target Analyst Ratings

Morning Market Movers

Courtesy of Benzinga.

Related SCOK
Worst Performing Industries For October 14, 2014
SinoCoking Announces Entry Into Agreement For $14.3M Registered Direct Offering Of Common Shares and Warrants

Related NLNK
Benzinga's Top #PreMarket Gainers
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement For Development Of NLG919, An IDO Inhibitor In Phase 1, And Research Collaboration For The Discovery Of Next Generation IDO/TDO Inhibitors
Stomach-Churning Ride for Ebola Stocks (Fox Business)

SinoCoking Coal and Coke Chemical Industries (NASDAQ: SCOK) shares jumped 43.66% to $3.38 as aboveground syngas facility commenced operations.

NewLink Genetics (NASDAQ: NLNK) shares climbed 18.91% to $34.90 after the company announced an exclusive worldwide licensing agreement for development of NLG919 and research collaboration for the discovery of next generation IDO/TDO inhibitors.

ShoreTel (NASDAQ: SHOR) shares rose 16.74% to $7.60 after Mitel Networks (NASDAQ: MITL) proposed to acquire ShoreTel for $8.10 per share in cash.

Apricus Biosciences (NASDAQ: APRI) gained 12.20% to $1.84 after the company reported that it has licensed US rights for Fispemifene, a Phase 2b ready asset, from Forendo Pharma for an upfront license fee of $12.5 million.

Cleco (NYSE: CNL) climbed 9.99% to $53.09 after the company agreed to be acquired by North American Investor Group led by Macquarie Infrastructure for $55.37 per share in cash.

Gannett Co (NYSE: GCI) shares rose 4.51% to $28.94 after the company reported better-than-expected profit for the third quarter.

Peabody Energy (NYSE: BTU) gained 4.08% to $11.48 after the company posted a narrower-than-expected loss for the third quarter.

Hasbro (NASDAQ: HAS) shares surged 2.53% to $55.22 after the company reported better-than-expected earnings for the third quarter.

Halliburton Company (NYSE: HAL) rose 1.16% to $53.21 after the company reported upbeat results for the third quarter and raised its quarterly dividend by 20%.

Posted-In: market moversNews Intraday Update Markets Movers


Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

Thank you for you time!


Chart School

Conference Board Leading Economic Index Increased in September

Courtesy of Doug Short.

The Latest Conference Board Leading Economic Index (LEI) for September is now available. The index rose 0.8 percent to 104.4. August was revised downward to 103.6 percent (2004 = 100). The latest number came in above the 0.6 percent forecast by

Here is an overview from the LEI technical notes:

The Conference Board LEI for the U.S. increased in September after no change in August. The financial components, along with initial claims for unemployment insurance and ISM® new orders, made the largest positive contributions this month. In the six-month period ending September 2014, the leading economic index increased 3.5 percent (about a 7.1 percent annual rate), faster than the growth of 2.7...

more from Chart School

Zero Hedge

Biotechs Hit Record High, +11.5% From Yellen's "Stretched Valuations" Warning

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

"Don't fight the Fed," unless of course the Fed says "sell." Since Janet Yellen's July 15th "Biotechs.. valuations are stretched" warning, investors have fought tooth-and-nail with the Fed to prove her wrong... Biotechs are now up 11.5% from that day at all-time record highs. And as a reminder bonds are in a bubble...




more from Tyler

Option Review

LUV Options Active Ahead Of Earnings

There is lots of action in Southwest Airlines Co. November expiry call options today ahead of the air carrier’s third-quarter earnings report prior to the opening bell on Thursday. Among the large block trades initiated throughout the trading session, there appears to be at least one options market participant establishing a call spread in far out of the money options. It looks like the trader purchased a 4,000-lot Nov 37/39 call spread at a net premium of $0.40 apiece. The trade makes money if shares in Southwest rally 9.0% over the current price of $34.32 to exceed the effective breakeven point at $37.40, with maximum potential profits of $1.60 per contract available in the event that shares jump more than 13% to $39.00 by expiration. In September, the stock tou...

more from Caitlin

Phil's Favorites

Larry Swedroe: Use Valuations for Expected Returns, Not Market Timing

Larry Swedroe: Use Valuations for Expected Returns, Not Market Timing

Courtesy of 

When forecasting investment returns, many individuals make the mistake of simply extrapolating recent returns into the future. Bull markets lead investors to expect higher future returns, and bear markets lead them to expected lower future returns. But the price you pay for an asset also has a great impact on future returns. Consider the following evidence:

The average historical P/E ratio for the market has been around 15. A study covering the period from 1926 through the second quarter of 1999 found that an investor buying stocks when the market traded at P/E ratios of between 14 and 16 e...

more from Ilene

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.

To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Insider Scoop

UPDATE: Brean Capital Initiates Coverage On GrubHub

Courtesy of Benzinga.

Related GRUB UPDATE: JMP Securities Initiates Coverage On GrubHub Inc Benzinga's Top Initiations Making Money With Charles Payne: 09/25/14 (Fox Business)

Brean Capital initiated coverage on GrubHub Inc (NYSE: GRUB) with a Hold rating.

Analyst Tom Forte noted that "catalysts for the stock include an accelerat... more from Insider


Sector Detector: Sharp selloff in stocks sets up long-awaiting buying opportunity

Courtesy of Sabrient Systems and Gradient Analytics

Last week brought even more stock market weakness and volatility as the selloff became self-perpetuating, with nobody mid-day on Wednesday wanting to be the last guy left holding equities. Hedge funds and other weak holders exacerbated the situation. But the extreme volatility and panic selling finally led some bulls (along with many corporate insiders) to summon a little backbone and buy into weakness, and the market finished the week on a high note, with continued momentum likely into the first part of this week.

Despite concerns about global economic growth and a persistent lack of inflation, especially given all the global quantitative easing, fundamentals for U.S. stocks still look good, and I believe this overdue correction ultimately will shape up to be a great buying opportunity -- i.e., th...

more from Sabrient

Digital Currencies

Goodbye War On Drugs, Hello Libertarian Utopia. Dominic Frisby's Bitcoin: The Future of Money?

Courtesy of John Rubino.

Now that bitcoin has subsided from speculative bubble to functioning currency (see the price chart below), it’s safe for non-speculators to explore the whole “cryptocurrency” thing. So…is bitcoin or one of its growing list of competitors a useful addition to the average person’s array of bank accounts and credit cards — or is it a replacement for most of those things? And how does one make this transition?

With his usual excellent timing, London-based financial writer/actor/stand-up comic Dominic Frisby has just released Bitcoin: The Future of Money? in which he explains all this in terms most readers will have no tr...

more from Bitcoin


Swing trading portfolio - week of October 20th, 2014

Reminder: OpTrader is available to chat with Members, comments are found below each post.


This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...

more from OpTrader

Market Shadows

Falling Energy Prices: Sober Look takes a Sober Look

Falling Energy Prices: Sober Look takes a Sober Look

What do falling energy prices mean for the US consumer? Sober Look writes a brief yet thorough overview of the consequences of the correction in the price of crude oil. There are good aspects, particularly for the consumer, bad aspects, and out-right ugly possibilities. For more on this subject, read James Hamilton's How will Saudi Arabia respond to lower oil prices?  In previous eras, Saudi Arabia would tighten the supply to help increase prices, but in this "game of chicken," the rules m...

more from Paul

Stock World Weekly

Stock World Weekly

Newsletter writers are available to chat with Members regarding topics presented in SWW, comments are found below each post.

Here's this week's Stock World Weekly. Just sign in with your PSW user name and password. (Or take a free trial.)

#457319216 /



more from SWW


Biotechs & Bubbles

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Well PSW Subscribers....I am still here, barely.  From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so a small amount.

First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices.  Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment.  Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer.  For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...

more from Pharmboy

FeedTheBull - Top Stock market and Finance Sites

About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>

As Seen On:

About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>